GlassScriptPhysician profile
Andrey Pavlov
NPI 1174818520
$1,916.45
in general payments reported to CMS, 2019-2025
14 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $216 · 2021: $216 · 2022: $83.73 · 2023: $21.54 · 2024: $428 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Education: $83.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.53 |
| Education | $83.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $787.09 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $313.64 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.28 | 2019-2025 | Ofev, Jascayd |
| Amgen INC. | $141.75 | 2023-2025 | Tezspire |
| Insmed, INC. | $92.88 | 2024-2025 | Arikayce, Brinsupri |
| Resmed Corp | $65.72 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $61.51 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $57.55 | 2020-2024 | |
| Philips North America LLC | $48.64 | 2025 | Vest Therapy Und |
| Genentech USA, INC. | $40.17 | 2019 | |
| Genzyme Corporation | $38.62 | 2019-2025 | |
| Baxter Healthcare | $24.88 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $24.37 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $20.35 | 2024 | Prolastin-C Liquid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrey Pavlov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.